Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BCAXBCAX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BICARA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 520,567 shares of BCAX (BICARA THERAPEUTICS INC), worth $15.5M as of 2026-Q2. The position was decreased (-6.9% shares). BCAX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$15.5M

Current Shares

520,567

Total Value Change

+$12.3M

Total Shares Change

+340,818

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
520,567
-6.9%
$15.5M0.0%$29.69
0
2026-Q1
Increased
558,964
+1.2%
$11.1M0.0%$17.92
28
2025-Q4
Increased
552,331
+137.3%
$9.3M0.0%$16.12
45
2025-Q3
Increased
232,761
+53.3%
$3.7M0.0%$13.87
37
2025-Q2
Increased
151,857
+20.8%
$1.4M0.0%$8.71
30
2025-Q1
Decreased
125,695
-30.1%
$1.6M0.0%$13.40
0
2024-Q4
New
179,749
-
$3.1M0.0%$17.00
37

Other major holders of BCAX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used